Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
HIV did not affect HCC recurrence or survival after LT
Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster presentation at CROI 2015.
Combination of trastuzumab, XELOX shows promise for advanced gastric cancer
The addition of trastuzumab to the standard first-line regimen of capecitabine plus oxaliplatin created a highly effective and well-tolerated combination for the treatment of advanced gastric cancer, according to results of a phase 2 study.
Log in or Sign up for Free to view tailored content for your specialty!
Smoking increases mortality risk in patients with colorectal cancer
Cigarette smoking is associated with a higher mortality rate among patients with invasive, nonmetastatic colorectal cancer, according to results of a study led by investigators from the American Cancer Society.
Statin use may reduce risk for liver cancer
The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data.
Tumor location in colorectal cancer may predict survival
The location of tumors in the colon may be an important prognostic factor for patients with treatment-naive metastatic colorectal cancer, according to study results.
Nexavar, TACE well tolerated in elderly patients with HCC
Nexavar and transarterial chemoembolization combination therapy for advanced hepatocellular carcinoma was well tolerated by elderly patients, according to study data.
HEAT Study: ThermoDox increased OS in patients with HCC
Updated results from the HEAT Study indicated an increased overall survival rate among patients with primary liver cancer when treated with ThermoDox combined with radiofrequency ablation, according to a press release.
Older donor age, nonlocal distribution potentially increase HCC recurrence after liver transplant
Liver transplant recipients were at increased risk for hepatocellular carcinoma recurrence if they received a liver from a donor aged at least 60 years or from a nonlocal share distribution, according to study data.
FDA grants orphan drug designation to Reolysin for pancreatic cancer
The FDA granted orphan drug status to pelareorep for the treatment of pancreatic cancer, the drug’s manufacturer announced today.
Analysis of microendoscopic images helps diagnose esophageal squamous neoplasia
High-resolution microendoscopy with quantitative image analysis was useful for identifying esophageal squamous neoplasia with high sensitivity and specificity, according to recent study data.
-
Headline News
Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain
October 23, 20242 min read -
Headline News
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
October 23, 20243 min read -
Headline News
CDC: 1 dead in multistate E. coli outbreak linked to McDonald’s Quarter Pounders
October 22, 20241 min read
-
Headline News
Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain
October 23, 20242 min read -
Headline News
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
October 23, 20243 min read -
Headline News
CDC: 1 dead in multistate E. coli outbreak linked to McDonald’s Quarter Pounders
October 22, 20241 min read